Search results
Showing 46 to 60 of 88 results for vte
Venous thromboembolism - apixaban (acute medical illness) [ID310]
Discontinued Reference number: GID-TAG419
This guideline covers assessing and managing psoriasis in adults, young people and children. It aims to improve long-term disease control and quality of life for people with psoriasis.
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (IPG554)
Evidence-based recommendations on balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension in adults. This involves inserting and inflating a balloon in blocked blood vessels in the lungs to improve blood flow.
Research into the long-term treatment effects of rivaroxaban is needed.
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism Number TA287 Date issued June 2013 Other
Evidence-based recommendations on individually magnetic resonance imaging-designed unicompartmental interpositional implant insertion for osteoarthritis of the knee. This involves inserting an individually designed implant at the knee between the thigh and shin bones to realign the knee and prevent bone-on-bone rubbing.
View recommendations for IPG317Show all sections
Sections for IPG317
Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis (IPG230)
Evidence-based recommendations on arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis. This involves flushing the joint with fluid, which is introduced through small incisions in the knee.
View recommendations for IPG230Show all sections
Sections for IPG230
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism Number TA287 Date issued June 2013 Other
details Comes from guidance Apixaban for preventing venous thromboembolism after hip or knee replacement surgery Number TA245
on oxygenation and lead to a reduction in complications such as venous thromboembolism and hypostatic pneumonia. There could be benefits...
inexpensive. Source guidance details Comes from guidance Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep...
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)
This guideline covers identifying and assessing risk of cardiovascular disease (CVD) in adults without established CVD. It covers lifestyle changes and lipid-lowering treatment (including statins) for primary and secondary prevention of CVD, and includes guidance for people who also have diabetes or chronic kidney disease.
Evidence-based recommendations on bevacizumab (Avastin), with capecitabine, for treating metastatic breast cancer in adults.
Evidence-based recommendations on bevacizumab (Avastin), with gemcitabine and carboplatin, for treating platinum-sensitive advanced ovarian cancer in adults.
Evidence-based recommendations on lenalidomide (Revlimid) for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality in adults.
View recommendations for TA322Show all sections
This guideline covers diagnosing and managing abdominal aortic aneurysms. It aims to improve care by helping people who are at risk to get tested, specifying how often to monitor asymptomatic aneurysms, and identifying when aneurysm repair is needed and which procedure will work best.